KENNETH RAPOZA – INDIAN DRUG COMPANY FAILS FDA INSPECTION 5 25 24KENNETH RAPOZA – INDIAN DRUG COMPANY FAILS FDA INSPECTION 5 25 24
American Medicine Today - Radio
A PHARMACEUTICAL COMPANY IN INDIA RECENTLY FAILED 10 REQUIREMENTS FOR “GOOD MANUFACTURING PRACTICES” FOLLOWING INSPECTION OF THE FACILITIES BY THE FDA. SO WHAT DOES THAT MEAN FOR THE CONTINUING DRUG SHORTAGES? WE SPEAK WITH KENNETH RAPOZA, INDUSTRY...
10:35•25 May 2024
FDA Failures and Drug Shortages: What’s Really Happening?
Episode Overview
- FDA challenges in balancing safety and drug supply
- Impact of FDA inspection failure on Indian pharmaceutical company
- Dominance of Indian companies in the U.S. generics market
- Concerns over drug shortages and safety regulations
- Need for greater oversight in pharmaceutical manufacturing
“The FDA is absolutely in a rock and a hard place because they have to balance those two things: safety and supply. The United States has about 320 drugs that we take regularly or that hospitals use every day in surgeries that we don't make here.”
Ever wondered what happens when a pharmaceutical company fails an FDA inspection? In this episode of 'American Medicine Today', Kenneth Rapoza, an industry analyst from the Coalition for a Prosperous America, takes us behind the scenes of a recent inspection failure at an Indian drug company. This isn't just a bureaucratic hiccup; it has real-world consequences for drug shortages and patient safety in the U.S.
Kenneth, who’s also a former Wall Street Journal correspondent, breaks down the ten requirements the company failed to meet and why these lapses matter. He discusses the dominance of Indian companies in the U.S. generics market and the ripple effects of relying heavily on foreign drug suppliers. The conversation also raises critical questions about the balance between maintaining stringent safety standards and ensuring a steady drug supply.
If you're curious about how these issues affect your health and safety, this episode is a must-listen. It’s an eye-opener that blends expert insights with real-world implications, making it accessible and engaging for anyone concerned about healthcare.
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.
Related Episodes
Similar episodes from other shows in the catalogue.